S

SFJ Pharmaceuticals, Inc.

28 employees

SFJ is a global Pharmaceutical company with an innovative business model that provides a financially advantageous and creative approach.

Investor insights

Sectors invested in

Biotechnology2
Chemical1
Medical1
Pulmonary Arterial Hypertension1
slow absorption1
Orphan diseases1
Ticagrelor reversal agent1
Vasoactive Intestinal Peptide1
phase transition1
improved biotherapeutics1
DMD cardiomyopathy1
cardiopulmonary disorders1
Pharmaceutical1
Heart failure1
Medical Device1
Elastin-like polypeptide biopolymer1
Drug Development and Polymer Conjugate Chemistry1
Therapeutics1
Health Care1

Funding rounds participated in

$135M sweet spot round size

Most of their 2 investments are in rounds between $120M and $150M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Health Care

Date founded

2009

Investments made

N

Nektar Therapeutics raised $150M on February 17, 2021

Investors: SFJ Pharmaceuticals, Inc.

P

PhaseBio Pharmaceuticals, Inc. raised $120M on January 13, 2020

Investors: SFJ Pharmaceuticals, Inc.

Funding rounds raised

Total raised

$45M

from 7 investors over 7 rounds

S

SFJ Pharmaceuticals, Inc. raised $30M on October 1, 2013

Investors: Clarus Ventures, LLC

S

SFJ Pharmaceuticals, Inc. raised $13M on April 1, 2013

Investors: Clarus Ventures, LLC

S

SFJ Pharmaceuticals, Inc. raised $500K on October 1, 2012

Investors: Clarus Ventures, LLC

S

SFJ Pharmaceuticals, Inc. raised $21M on July 1, 2012

Investors: Clarus Ventures, LLC

S

SFJ Pharmaceuticals, Inc. raised $35M on April 1, 2012

Investors: Clarus Ventures, LLC

S

SFJ Pharmaceuticals, Inc. raised $45M on March 16, 2009

Investors: Clarus Ventures, LLC and Abingworth

FAQ